Rallybio Corporation
NASDAQ:RLYB
1.1 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -74.564 | -66.654 | -47.013 | -26.447 | -17.563 |
| Depreciation & Amortization
| 0.15 | 0.167 | 0.109 | 0.062 | 0.026 |
| Deferred Income Tax
| 0.099 | 0 | 0 | 0 | 0.103 |
| Stock Based Compensation
| 10.92 | 9.499 | 3.645 | 0.704 | 0.194 |
| Change In Working Capital
| 4.277 | -0.936 | -3.779 | 2.12 | 2.07 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.099 | 0.487 | -0.976 | 0.723 | 0.728 |
| Other Working Capital
| 4.376 | -1.423 | -2.803 | 1.397 | 1.342 |
| Other Non Cash Items
| -1.147 | 0.64 | 1.505 | 1.522 | 0.144 |
| Operating Cash Flow
| -60.265 | -57.284 | -45.533 | -22.039 | -15.026 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.012 | -0.054 | -0.333 | -0.137 | -0.188 |
| Acquisitions Net
| -2.25 | -0.3 | -2 | -1.935 | 0 |
| Purchases Of Investments
| -110.664 | -201.316 | -2 | -1.935 | 0 |
| Sales Maturities Of Investments
| 138.334 | 89.5 | 2.002 | 1.937 | 0 |
| Other Investing Activites
| 2.25 | -0.112 | -0.002 | -0.002 | 0 |
| Investing Cash Flow
| 27.658 | -112.17 | -2.333 | -2.072 | -0.188 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.143 | 51.078 | 86.2 | 145.205 | 31.6 |
| Common Stock Repurchased
| 0.282 | 0.217 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.139 | -0.693 | -3.233 | -0.319 | -0.033 |
| Financing Cash Flow
| 0.143 | 51.078 | 82.967 | 144.886 | 31.567 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -32.464 | -118.376 | 35.101 | 120.775 | 16.353 |
| Cash At End Of Period
| 24.494 | 56.958 | 175.334 | 140.233 | 19.458 |